Prosthetic Heart Valves Market Insights by 2018 | Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC, Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and Neovasc

Competition in the prosthetic heart valves market is intense and in order to maintain their competitiveness, companies are adopting strategies such as inorganic growth, merger and acquisition and product innovation. Product innovation continues to drive pricing, which acts as a huge barrier for new entrants in the market.

The key players operating in the global prosthetic heart valves market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC, Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and Neovasc Inc.

Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/69

Market players are also investing in expanding their product portfolios, resulting in their growing pipelines in the prosthetic heart valves market. For instance, in March 2017, Boston Scientific Corporation acquired Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices. The Symetis portfolio includes the Acurate TA and Acurate neo/TF valve systems for use in the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis, which are sold in Europe and in other geographies outside of the United States. Symetis is also developing the ACURATE neo/AS next generation valve system, currently in a clinical trial intended to serve as the basis for a future CE mark application.

For instance, in 2016, St. Jude Medical Inc. launched the advanced tissue valve—the Trifecta valve with Glide Technology (GT)—for the treatment of patients with unhealthy, damaged or malfunctioning aortic heart valves in U.S. This Trifecta GT tissue valve offers patients enhanced valve delivery to ease implantation in challenging anatomies and during minimally invasive surgical approaches.

However, if the cost of this technology can be reduced, as is expected with the approval of next-generation devices by manufacturers, the prosthetic heart valve will be the most lucrative market for medical device companies. For instance, in February, 2018, Medtronic Plc’s product- Mosaic bioprosthetic heart valve demonstrated positive performance and Long-Term Durability Up to 12 Years in International Study. This clinical study supports the long-term, robust performance of the Mosaic valve, and reinforces the trend in the decreasing average age of recipients.

The aging population and increasing patient population of heart disease are expected to drive demand for prosthetic heart valve-based treatment in the future. For instance, According to the statistics of World Health Organization in 2012, 17.6 million people died of cardiovascular disease (CVD) worldwide, and proportionally, this accounts for 31.43% of global mortality. Moreover, The emergence of valve-in-valve procedures serves as a significant market opportunity for the prosthetic heart valve.

Get Discount @ https://www.coherentmarketinsights.com/insight/request-discount/69

Detailed Segmentation:

Global Prosthetic Heart Valves Market, By Product Type:
Transcatheter Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Global Prosthetic Heart Valves Market, By End User:
Hospitals
Ambulatory Surgical Centers

Table of Contents

Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Regulatory Scenario
Industry Trends
Technological Advancements
PEST Analysis
PORTER’S Five Forces
Global Prosthetic Heart Valves Market, By Product Type, 2017–2025, (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Transcatheter Heart Valves
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Mechanical Heart Valves
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Tissue Heart Valves
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Global Prosthetic Heart Valves Market, By End User, 2017–2025, (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)

Send Enquiry on this report @ https://www.coherentmarketinsights.com/insight/buy-now/69

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.